Biotech Continues To Offer Huge Returns For Investors
Investment U | Dec 06, 2015 12:09AM ET
Earlier this year, we argued investors should snatch up biotech bargains while they were hot.
And, boy, were we right.
This week’s chart looks at the performance of the ARCA Biotechnologyand the S&P 500 since the beginning of the year.
As you can see, the biotech sector dropped more than 20% in August. It then made a solid 14% recovery before dropping again in September.
Since then, biotech is up more than 15%.
It all goes to support our thesis that big drops in this volatile sector are typically followed by even bigger uptrends.
Now, biotech stocks certainly come with their fair share of risks. But investors have a better chance of quickly generating huge returns here than in the broader market.
In fact, so far this year the S&P 500 has struggled to stay positive. It’s averaged only a 0.8% return. Compare that to the average 9.5% return from the biotech index.
Over the past 20 years, the healthcare sector as a whole has had one of the highest annualized gains of any other asset class... more than 12%.
And it’s showing no sign of letting up.
If you heeded our advice and grabbed some bargain biotech stocks, you likely turned a nice profit. If you didn’t, don’t worry. There are still plenty of opportunities ahead.
Recently, The Oxford Club’s No. 1 biotech enthusiast Marc Lichtenfeld identified what has the potential to be a $230 billion trend in the sector. This discovery not only could save your life, but also could make you a fortune.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.